EyePoint Plc (EYPT)

18.27 -0.11 (-0.60%) USD  |  NASDAQ  |  Dec 24, 12:59
18.24 -0.03 (-0.16%) After-Hours: 13:59
More

EyePoint SG&A Expense (TTM): 52.96M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for EYPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. 351.68M
Agios Pharmaceuticals, Inc. 180.37M
Viking Therapeutics, Inc. 52.36M
NovaBay Pharmaceuticals, Inc. 8.584M
Palatin Technologies, Inc. 7.449M